Clinical Trial Update: A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase 1/2 study evaluating sildenafil for the treatment of lymphatic malformations (lymphangioma) are reported; the trial conducted by Stanford U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioma
• Lymphatic Malformation

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Stanford University | Conditions: Lymphangioma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-06-12